Ankylosing spondylitis / axial SpA treatment and management

What is ankylosing spondylitis (axial spondyloarthritis) management?

Ankylosing spondylitis (AS), now usually called axial spondyloarthritis (axial SpA), is a long-term inflammatory condition that mainly affects the spine and the joints where the spine meets the pelvis. It causes back pain and stiffness that is often worse with rest and in the morning, and better with movement. It can also affect other joints, the tendons, the eyes and, in some people, the bowel or skin.

'Management' means the whole plan to keep axial SpA under control, not a single treatment. The foundation is regular exercise and keeping active to maintain posture and spinal movement, combined with medicines to control inflammation, and support with work, fatigue and daily life. A rheumatologist usually leads this, often with a physiotherapist.

Medicines usually start with anti-inflammatories (NSAIDs). If these are not enough, biologic or targeted treatments that block specific inflammatory signals can be used. Treatment is reviewed against agreed targets, and tailored to how active the disease is and which parts of the body are affected.

It is important to be realistic. Treatment can control symptoms well and help keep the spine mobile, but it does not cure the condition, and over years some people develop stiffening of the spine. Exercise is not an optional extra; it is one of the most important parts of management. Good care combines movement, medicine and support.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Exercise and NSAIDs versus biologics

Exercise stays important whatever medicines are used. Biologics are added when inflammation is not controlled by NSAIDs, and bring extra benefit but also extra monitoring and infection risk.

Preparing for your treatment

• Bring a note of your symptoms: where the pain and stiffness are, how long morning stiffness lasts, what helps, and any eye, bowel, skin or other joint problems.
• Bring all your medicines and supplements, and any allergies or past drug reactions.
• Have recent blood tests and any X-rays or MRI scans available, and previous clinic letters if you have them.
• Tell the team about other health conditions, especially infections, eye inflammation (iritis/uveitis) or bowel problems.
• If a biologic is being considered, expect screening for tuberculosis and hepatitis, and sort out vaccinations beforehand where possible.
• Tell the team if you could be pregnant, are planning pregnancy or are breastfeeding, as this affects medicine choice.
• Think about your goals for activity, work and exercise, and be ready to discuss starting or building an exercise routine.

What happens

At a rheumatology appointment, the clinician asks about your back and joint symptoms, morning stiffness, and any eye, bowel or skin problems, and examines your spine and joints for movement and tenderness. Blood tests and imaging (X-ray or MRI) help confirm the picture and judge how active the disease is.

Together you agree a plan. The foundation is usually an exercise and physiotherapy programme, with an NSAID to control pain and stiffness. You are shown what exercises help and how to take medicines safely.

If NSAIDs and exercise are not enough and the disease stays active, your team may discuss a biologic or targeted treatment, after screening. There is usually a defined point at which a treatment is judged to be working, using measures of pain, stiffness and function. You are reviewed regularly, and should have a way to contact the team about flares or new symptoms, such as a painful red eye, between appointments.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

The trade-offs differ by treatment: regular NSAIDs carry stomach, kidney and blood-pressure risks, while biologics dampen the immune system and raise infection risk, needing screening and monitoring. The condition itself can cause eye inflammation and, over years, spinal stiffening, so good control matters. Ask your team how each treatment is monitored, what to do during infections, what eye symptoms to watch for, and how exercise fits into your plan.

Published figures to discuss

How well treatment works, and how likely side effects are, varies with the individual, the medicines used, how active the disease is and other conditions such as bowel disease or eye inflammation. Many people respond well to biologics, but not everyone, and treatments may need switching. Long-term outcomes, including how much spinal stiffening develops, vary widely. Because of this, outcomes and risks should be discussed as cautious, individual estimates rather than fixed figures.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

This is ongoing care rather than a procedure with a recovery period. What matters is how your pain, stiffness and movement change over weeks to months, how well you keep up your exercise, and how the plan is reviewed and adjusted against agreed targets.

• A gradual rather than sudden improvement in pain and stiffness over weeks
• Morning stiffness that eases with movement and exercise
• Some good days and worse days, especially during a flare
• Needing to keep up exercise regularly to maintain the benefit
• Needing monitoring blood tests if you are on a biologic or targeted treatment

Aftercare

• Keep up your exercise and physiotherapy programme; this is one of the most important parts of treatment.
• Take NSAIDs as advised, with stomach protection if recommended, and report indigestion or stomach pain.
• If on a biologic, keep up monitoring blood tests and watch for signs of infection.
• Avoid live vaccines if on a biologic unless your team agrees, and have flu and recommended COVID-19 vaccines.
• Seek urgent eye care for a painful red eye or sudden vision change, which can be linked to the condition.
• Tell other clinicians, dentists and surgeons what medicines you take.
• Have a flare plan and know who to contact when symptoms worsen.

• An exercise and physiotherapy plan you can follow
• A clear, written treatment and flare plan
• TB and hepatitis screening done if a biologic is planned
• Monitoring blood tests booked if on a biologic, with a way to see results
• Vaccinations reviewed (live vaccines avoided on biologics; flu/COVID arranged)
• A named contact route for flares, infections and eye symptoms
• A list of your current medicines, including how and when to take them

⚠ Get urgent help if…

• A painful, red, light-sensitive eye or sudden change in vision, which needs urgent eye assessment
• A high temperature, shaking chills or feeling very unwell, especially on a biologic (possible serious infection)
• A productive cough, night sweats or weight loss on a biologic (possible tuberculosis)
• Black or bloodstained stools, vomiting blood or severe stomach pain (possible NSAID-related bleeding)
• New, sudden severe back or neck pain after a fall or injury, especially if the spine is stiffened (seek urgent help)
• New numbness, weakness, or loss of bladder or bowel control (seek urgent help)
• Yellowing of the skin or eyes, or unusual tiredness (possible liver problem)

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result is axial SpA that is well controlled: less back and joint pain, less morning stiffness, better movement and function, and a maintained ability to stay active and work. This is judged over weeks to months against agreed targets and reviewed regularly, not from a single appointment.

Good control improves quality of life and helps keep the spine mobile, but it is not a cure, and some people still develop spinal stiffening over time. Keeping up exercise is essential to maintaining the benefit. If one treatment is not enough or stops working, the plan can be changed, so a single result is part of an ongoing plan.

Axial SpA is a lifelong condition, so management continues over the long term, including through periods when you feel well. Exercise needs to be ongoing to maintain mobility. Many people stay on the same treatment for years, while others need medicines changed or stepped up. Some who do very well on a biologic may, under guidance, reduce the dose or spacing, but treatment and exercise are usually continued because symptoms can return. The plan is reviewed over time.

Related tests, treatments or support

Care combines exercise and physiotherapy, NSAIDs, and, when needed, biologic or targeted treatment, with local injections or DMARDs for involved joints. The condition can affect the eyes, bowel and skin, so care is sometimes coordinated with eye, gut or skin specialists. Your team coordinates medicines so they work together safely, including around vaccinations, infections and operations, while keeping exercise central.

Follow-up & long-term care

Follow-up is regular and ongoing: reviews of disease activity, exercise and function, monitoring blood tests if on a biologic, and checks for side effects and infections, with a defined point to judge whether each treatment is working. You should be able to contact your team between appointments about flares, infections, eye symptoms or warning signs. Care may be shared with your GP and, where relevant, eye, gut or skin specialists.

• Keep up your exercise and physiotherapy programme long-term.
• Take NSAIDs as advised, with stomach protection if recommended.
• If on a biologic, attend monitoring blood tests and keep vaccinations up to date, avoiding live vaccines.
• Know what to do with your medicines during infections or before operations.
• Seek prompt eye care for a painful red eye.
• Review treatment regularly so it can be stepped up or carefully adjusted.

Repeat, follow-on and what comes next

• Biologics are judged at a set point and switched if there has not been an adequate response.
• It is common to adjust NSAIDs or switch between biologics to find the right control.
• Some people who do very well may reduce the dose or spacing of a biologic under guidance.
• Flares may need extra short-term treatment and a review of the longer-term plan.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• An ongoing, tailored exercise and physiotherapy plan.
• Regular review of disease activity against a clear target.
• Reliable monitoring blood tests on biologics, with results acted on.
• Clear advice to seek urgent eye care for a painful red eye.
• A written flare plan, a named contact route, and vaccination and infection advice.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• The rheumatology consultation fee and the length and number of appointments
• Blood tests and any X-rays or MRI scans
• Physiotherapy sessions, which are an important part of treatment
• The medicines used, from inexpensive NSAIDs to costly biologics and targeted tablets
• Screening tests and ongoing monitoring blood tests if a biologic is used
• Review appointments and any local injections
• Input from eye, gut or skin specialists if other areas are involved

• The consultation fee and what each appointment includes
• Whether physiotherapy is included or charged separately
• Which tests and scans are included, and which are extra
• The cost of the proposed medicines and who prescribes and monitors them
• Screening and monitoring blood tests if a biologic is planned
• What happens, and what it costs, during a flare or if a medicine must be switched
• How private and NHS care, and any other specialists, will be coordinated

On the NHS? Axial spondyloarthritis is diagnosed and managed on the NHS, including specialist review, physiotherapy, medicines and monitoring; private care is mostly used for speed, choice of specialist or convenience rather than different treatment.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• How active is my disease, and what are we aiming for?
• What exercise and physiotherapy plan is right for me?
• Which medicine are you suggesting first, and why this one for me?
• When would we consider a biologic, and what screening and monitoring does it need?
• What eye symptoms should make me seek urgent help?
• What is my flare plan, and who do I contact when symptoms worsen?
• How does treatment fit with any plans for pregnancy or breastfeeding?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my treatment, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this treatment not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for ankylosing spondylitis / axial spa treatment and management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS — Ankylosing spondylitis treatment NASS — National Axial Spondyloarthritis Society NASS — Biologic therapy NICE NG65 — Spondyloarthritis in over 16s: diagnosis and management Versus Arthritis — Axial spondyloarthritis (ankylosing spondylitis) British Society for Rheumatology — Guidelines

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.